CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has promoted Barry Greene to the new position of President and Chief Operating Officer. Mr. Greene previously held the title of Chief Operating Officer. In his new role, he will assume responsibility for business, corporate, and commercial development activities and will continue to report to Dr. John Maraganore, who remains the company’s Chief Executive Officer.
